DSS.AMEXDss, INC
10-Q: DSS Inc. Reports Mixed Q3 Results Amidst Strategic Shifts and Restructuring
Sentiment:
Quarterly Report
DSS Inc. experienced a mixed third quarter with increased revenue in some segments offset by losses and strategic changes impacting overall performance.
Capital raiseImpact Biomedical Inc. completed an initial public offering (IPO) on September 17, 2024, raising approximately $3.7 million in net proceeds.The company issued warrants to the Representative and its affiliates to purchase shares of Common Stock equal to 5% of the Common Stock issued and sold in the offering.
Worse than expectedThe company's net investment income decreased by 58% due to non-accrual loans, indicating a worse than expected performance in this area.Direct marketing revenue decreased by 100% as the company shifts its business model, indicating a worse than expected performance in this area.Total revenue for the nine months ended September 30, 2024, decreased by 28% compared to the same period in 2023, indicating a worse than expected performance in this area.
Summary
- DSS Inc. reported a net loss of $5.7 million for the third quarter of 2024, compared to a $6.7 million loss in the same period of 2023.
- Total revenue for the quarter increased by 34% year-over-year, reaching $5.6 million, driven primarily by a 46% increase in printed products revenue and a 110% increase in rental income.
- However, net investment income decreased by 58% due to non-accrual loans, and direct marketing revenue declined by 100% as the company shifts its business model.
- For the nine months ended September 30, 2024, the company's net loss was $15.8 million, a significant improvement from the $33.1 million loss in the same period of 2023.
- Total revenue for the nine-month period decreased by 28% to $13.7 million, with declines in rental income and direct marketing revenue.
- The company's cash and cash equivalents stood at $11.6 million as of September 30, 2024.
- The company has taken steps to sell real estate holdings of approximately $46.1 million and reduce expenses to improve its financial position.
Sentiment
Score: 4
Explanation: The document presents a mixed picture with some positive developments (revenue growth in certain segments, reduced net loss) offset by significant challenges (declining investment income, direct marketing losses, loan defaults, ineffective controls). The overall sentiment is cautiously negative due to the ongoing financial and operational risks.
Positives
- Printed products revenue increased by 46% in the third quarter, indicating strong performance in this segment.
- Rental income increased by 110% in the third quarter, showing positive results from real estate investments.
- The net loss for the nine months ended September 30, 2024, decreased significantly compared to the same period in 2023, indicating improved financial performance.
- The company has taken steps to sell real estate holdings and reduce expenses to improve its financial position.
Negatives
- Net investment income decreased by 58% in the third quarter due to non-accrual loans, indicating potential issues with loan portfolio management.
- Direct marketing revenue decreased by 100% in the third quarter, reflecting challenges in the transition to a new business model.
- Total revenue for the nine months ended September 30, 2024, decreased by 28% compared to the same period in 2023.
- The company has incurred operating losses and negative cash flows from operating and investing activities over the past two years.
Risks
- The company's loan portfolio is experiencing issues with non-accrual loans, impacting net investment income.
- The transition in the direct marketing business model has resulted in a complete loss of revenue in that segment.
- The company has a history of operating losses and negative cash flows, raising concerns about its long-term financial sustainability.
- The company is in default on certain loan agreements, which could lead to further financial challenges.
- The company's disclosure controls and procedures were not effective as of September 30, 2024, indicating potential weaknesses in financial reporting.
Future Outlook
The company believes it can continue as a going concern due to its cash balance, the sale of marketable securities, and the sale of real estate holdings. The company also plans to materially reduce expenses and cash burn at all corporate and business line levels.
Management Comments
- The company has taken steps, and will continue to take measures, to materially reduce the expenses and cash burn at all corporate and business line levels.
- The company believes the above would allow us to fund our nine business lines current and planned operations for the twelve months from the filing date of this Quarterly Report.
Industry Context
The company operates in diverse sectors including product packaging, biotechnology, commercial lending, securities, and direct marketing. The mixed results reflect the challenges of managing such a diverse portfolio, with some segments showing growth while others struggle. The company's strategic shift in direct marketing and its efforts to divest real estate assets are indicative of a broader restructuring effort to focus on core competencies and improve financial stability.
Comparison to Industry Standards
- The company's performance is mixed when compared to industry standards. The 46% increase in printed products revenue is a positive sign, but the 100% decline in direct marketing revenue is concerning.
- The company's net loss of $15.8 million for the nine months ended September 30, 2024, is a significant improvement compared to the $33.1 million loss in the same period of 2023, but still indicates financial challenges.
- The company's cash position of $11.6 million is relatively low compared to industry peers, and the company's reliance on asset sales to improve its financial position is a risk factor.
- The company's loan portfolio is experiencing issues with non-accrual loans, which is a concern compared to industry standards for financial institutions.
- The company's disclosure controls and procedures were not effective as of September 30, 2024, which is a significant concern compared to industry standards for public companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Interim Chief Executive Officer | Frank D. Heuszel | Jason Grady | Unknown | Unknown |
Legal Proceedings
- The company is in default on certain loan agreements, and demand was made for final payment to be made by December 22, 2023.
Related Party Transactions
- The company owns shares of Alset International Limited, where the Chairman of DSS is also the Executive Director and CEO.
- The company has loan agreements and promissory notes with BMI Capital International LLC, a related party.
- The company has a promissory note with VEII, Inc., where the Chairman of DSS is also on the board of directors.
Stakeholder Impact
- Shareholders may be concerned about the company's ongoing losses and the effectiveness of its internal controls.
- Employees may be affected by the company's cost-cutting measures and restructuring efforts.
- Customers may experience changes in product offerings and services due to the company's strategic shifts.
- Creditors may be concerned about the company's ability to repay its debts, given the loan defaults and financial challenges.
Next Steps
- The company will continue to take measures to materially reduce expenses and cash burn.
- The company will continue to sell its real estate holdings assets of AMRE LifeCare and Winter Haven.
- The company will continue to monitor and assess its risk of not collecting amounts owed by customers and record its allowance for credit losses based on the results of this analysis.
Key Dates
| Date | Description |
|---|---|
| 2020-09-10 | DSS Securities, Inc. entered into a membership interest purchase agreement with BMI Financial Group, Inc. and BMI Capital International LLC. |
| 2020-12-30 | The Company signed a letter of intent with WestPark Capital Group, LLC. |
| 2021-02-19 | Impact BioMedical, Inc. entered into a promissory note with an individual. |
| 2021-05-14 | DSS Pure Air, Inc. entered a convertible promissory note with Puradigm, Inc. |
| 2021-08-01 | AMRE Shelton, LLC. entered into a loan agreement with Patriot Bank, N.A. |
| 2021-09-23 | APB entered into a refunding bond anticipatory note with Southeast Regional Management District. |
| 2021-10-13 | LVAM entered into loan agreements with BMIC and Lee Wilson Tsz Kin. |
| 2021-10-25 | APF entered into a loan agreement with Asili, LLC. |
| 2021-11-02 | AMRE LifeCare entered into a loan agreement with Pinnacle Bank. |
| 2021-12-28 | APF entered into a promissory note with WestPark Capital Group, LLC. |
| 2022-01-24 | APF and an individual entered into a promissory note. |
| 2022-03-02 | APF and WUURII Commerce, Inc. entered into a promissory note. |
| 2022-03-17 | AMRE Winter Haven, LLC and Pinnacle Bank entered into a term loan. |
| 2022-05-09 | DSS PureAir and Puradigm entered into a promissory note. |
| 2022-07-26 | APF and VEII, Inc. entered into a promissory note. |
| 2022-08-29 | DSS Financial Management Inc and BMI Capital, Inc. entered into a promissory note. |
| 2023-03-30 | Premier Packaging entered into a loan and security agreement with Union Bank & Trust Company. |
| 2023-03-31 | DSS Biohealth Security, Inc and an individual entered into a promissory note. |
| 2023-04-10 | The Company issued shares of common stock to Mr. Frank Heuszel, CEO of DSS. |
| 2023-05-04 | The Company distributed shares of SHRG to shareholders. |
| 2023-05-08 | DSS Financial Management Inc and BMIC entered into a promissory note. |
| 2023-05-10 | The Company's Board of Directors approved an amendment to the Articles of Incorporation of the Company. |
| 2023-05-11 | The Company effected a forward split. |
| 2023-06-27 | Decentralized Sharing Systems, Inc. and Stemtech Corporation entered into a convertible promissory note. |
| 2023-07-01 | The Company intended to sell its subsidiary, HWH World, Inc. to SHRG. |
| 2023-08-08 | DSS distributed shares of Impact Bios stock to its shareholders. |
| 2023-10-31 | The Company effected a reverse stock split of 1 for 55. |
| 2024-01-04 | The Company effected a reverse stock split of 1 for 20. |
| 2024-06-13 | The Company sold its retail space in Lindon, Utah. |
| 2024-08-29 | APF entered into a promissory note with WestPark. |
| 2024-09-16 | Impact Biomedical Inc. entered into an underwriting agreement. |
| 2024-09-17 | The Company closed the Offering of Impact Biomedical Inc. |
| 2024-11-11 | As of this date, there were 7,066,772 shares of the registrants common stock outstanding. |
Keywords
financial results, revenue, net loss, printed products, rental income, investment income, direct marketing, loan portfolio, real estate, restructuring, biotechnology, commercial lending, securities, financial statements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.